ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135077; 2) Community: the network communities that were significantly associated with the response to NSC 135077; 3) Molecule: the relationships between components within communities and NSC 135077; 4) MDR: the compounds that were significantly associated with the NSC 135077.

NSC Compound Enrichment Correlation
NSC 734231 2[4'aminobiphenyl]5,6dichlorobenzimidazole 0.0314734733353267 0.18481444
NSC 746035 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone 0.0314734733353267 0.36066529
NSC 747558 6-(4-Ethylphenyl)-2-benzenesulfonamidepyridazine-3(2H)-one 0.0314734733353267 0.29534479
NSC 753218 3-hydroxy-5,6-dihydro-6-imino-9-methoxyisoindolo-[2,1-a]quinoxaline 0.0314734733353267 0.17864673
NSC 755423 Null 0.0314734733353267 0.41248774
NSC 756233 GW435821X 0.0314734733353267 0.18681907
NSC 758356 2-(1-(4-chlorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide 0.0314734733353267 0.16303826
NSC 75890 1,9-Pyrazoloanthrone 0.0314734733353267 0.089368529
NSC 764037 BP-1-102 0.0314734733353267 -0.018474384
NSC 14050 Delagil 0.0329129886465387 0.056891177
Total:126  Current:92    [First] [Prev] [Next] [Last]